DrugCite
Search

PERSANTIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Persantin Adverse Events Reported to the FDA Over Time

How are Persantin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Persantin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Persantin is flagged as the suspect drug causing the adverse event.

Most Common Persantin Adverse Events Reported to the FDA

What are the most common Persantin adverse events reported to the FDA?

Headache
17 (1.9%)
Injection Site Pain
15 (1.67%)
Pyrexia
14 (1.56%)
Diarrhoea
13 (1.45%)
Dizziness
11 (1.23%)
Gastrointestinal Haemorrhage
11 (1.23%)
Nausea
10 (1.11%)
Thrombocytopenia
10 (1.11%)
Vomiting
10 (1.11%)
Anaemia
9 (1%)
Cerebral Haemorrhage
9 (1%)
Show More Show More
Cerebral Infarction
9 (1%)
Dyspnoea
9 (1%)
Epistaxis
9 (1%)
Myalgia
9 (1%)
Pneumonia
9 (1%)
Toxic Epidermal Necrolysis
9 (1%)
Transient Ischaemic Attack
9 (1%)
White Blood Cell Count Decreased
8 (.89%)
Back Pain
7 (.78%)
Chest Discomfort
7 (.78%)
Chest Pain
7 (.78%)
Feeling Abnormal
7 (.78%)
Haematemesis
7 (.78%)
Haemodialysis
7 (.78%)
Hepatitis Fulminant
7 (.78%)
Hypotension
7 (.78%)
Loss Of Consciousness
7 (.78%)
Malaise
7 (.78%)
Melaena
7 (.78%)
Paraesthesia
7 (.78%)
Cerebrovascular Accident
6 (.67%)
Duodenal Ulcer Haemorrhage
6 (.67%)
Dysarthria
6 (.67%)
Hypoxia
6 (.67%)
Interstitial Lung Disease
6 (.67%)
Pancytopenia
6 (.67%)
Septic Shock
6 (.67%)
Abdominal Pain Upper
5 (.56%)
Balance Disorder
5 (.56%)
Blood Alkaline Phosphatase Increase...
5 (.56%)
Blood Creatinine Increased
5 (.56%)
Blood Lactate Dehydrogenase Increas...
5 (.56%)
Blood Pressure Decreased
5 (.56%)
Drug Ineffective
5 (.56%)
Drug Level Increased
5 (.56%)
Escherichia Infection
5 (.56%)
Fall
5 (.56%)
Gastric Ulcer Haemorrhage
5 (.56%)
Granulocytopenia
5 (.56%)
Haemorrhage
5 (.56%)
Muscle Haemorrhage
5 (.56%)
Pain In Extremity
5 (.56%)
Peripheral Coldness
5 (.56%)
Suicide Attempt
5 (.56%)
Urine Output Decreased
5 (.56%)
Abdominal Discomfort
4 (.45%)
Anaphylactic Reaction
4 (.45%)
C-reactive Protein Increased
4 (.45%)
Cardiogenic Shock
4 (.45%)
Cerebellar Haemorrhage
4 (.45%)
Fatigue
4 (.45%)
Gastric Ulcer
4 (.45%)
Haemoglobin Decreased
4 (.45%)
Hepatitis
4 (.45%)
Liver Disorder
4 (.45%)
Liver Transplant
4 (.45%)
No Adverse Event
4 (.45%)
Pallor
4 (.45%)
Purpura
4 (.45%)
Somnolence
4 (.45%)
Abortion Spontaneous
3 (.33%)
Acute Myocardial Infarction
3 (.33%)
Acute Respiratory Distress Syndrome
3 (.33%)
Anorexia
3 (.33%)
Arrhythmia
3 (.33%)
Atrioventricular Block First Degree
3 (.33%)
Autoimmune Hepatitis
3 (.33%)
Blood Creatine Phosphokinase Increa...
3 (.33%)
Chest X-ray Abnormal
3 (.33%)
Cholestasis
3 (.33%)
Diverticulitis
3 (.33%)
Drug Exposure During Pregnancy
3 (.33%)
Duodenal Ulcer
3 (.33%)
Epilepsy
3 (.33%)
Erythema
3 (.33%)
Haematocrit Decreased
3 (.33%)
Haemorrhagic Diathesis
3 (.33%)
Hepatic Atrophy
3 (.33%)
Inflammation
3 (.33%)
Medication Error
3 (.33%)
Menorrhagia
3 (.33%)
Mouth Haemorrhage
3 (.33%)
Muscle Spasms
3 (.33%)
Myocardial Infarction
3 (.33%)
Neoplasm Malignant
3 (.33%)
Oedema Peripheral
3 (.33%)
Overdose
3 (.33%)
Pain
3 (.33%)
Platelet Count Decreased
3 (.33%)
Protein Total Decreased
3 (.33%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Persantin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Persantin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Persantin

What are the most common Persantin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Persantin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Persantin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Persantin According to Those Reporting Adverse Events

Why are people taking Persantin, according to those reporting adverse events to the FDA?

Transient Ischaemic Attack
24
Cerebrovascular Accident
20
Glomerulonephritis Chronic
19
Cardiac Stress Test
18
Product Used For Unknown Indication
18
Prophylaxis
18
Show More Show More
Thrombosis Prophylaxis
17
Proteinuria
16
Drug Use For Unknown Indication
16
Angina Pectoris
16
Nephrotic Syndrome
15
Myocardial Ischaemia
12
Hypertension
11
Glomerulonephritis Membranous
9
Stress Echocardiogram
7
Protein Urine
6
Myocardial Infarction
5
Cerebellar Infarction
5
Cerebrovascular Accident Prophylaxi...
5
Systemic Lupus Erythematosus
5
Cerebral Infarction
5
Cerebral Thrombosis
5
Lupus Nephritis
5
Cardiac Failure Congestive
5
Cardiovascular Event Prophylaxis
5
Kawasakis Disease
4
Cardiac Failure
4
Scan Myocardial Perfusion
4
Cardiomyopathy
3
Cerebrovascular Disorder
3
Platelet Aggregation Inhibition
3
Coronary Artery Surgery
3
Renal Disorder
3
Essential Thrombocythaemia
3
Nephritis
3
Amaurosis Fugax
3
Cerebral Ischaemia
2
Glomerulonephritis Proliferative
2
Blindness Transient
2
Arteriosclerosis Obliterans
2
Overdose
2
Acute Myocardial Infarction
2
Renal Failure Chronic
2
Lung Neoplasm Malignant
2
Ill-defined Disorder
2
Collagen Disorder
1
Peripheral Vascular Disorder
1
Hip Arthroplasty
1
Vasodilatation
1
Glomerulonephritis Rapidly Progress...
1
Malaise
1

Persantin Case Reports

What Persantin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Persantin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Persantin.